Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
13.68%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information
Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQZEVRA THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ZVRA - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 8.48M | 13.68% | $ 62.02M |
| 3/31/2025 | $ 8.59M | 21.15% | $ 40.59M |
| 12/31/2024 | $ 7.35M | 31.13% | $ 23.61M |
| 9/30/2024 | $ 5.91M | 23.86% | $ 24.79M |
| 6/30/2024 | $ 3.97M | 16.54% | $ 23.99M |
| 3/31/2024 | $ 2.05M | 7.33% | $ 28.01M |
| 12/31/2023 | $ 1.5M | 5.47% | $ 27.46M |
| 9/30/2023 | $ 763K | 4.61% | $ 16.56M |
| 6/30/2023 | $ 442K | 2.67% | $ 16.54M |
| 3/31/2023 | $ 281K | 3% | $ 9.37M |
Key Performance Insights, Last 5 Years
- ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 40.92%.
- Over the past 5 years, ZEVRA THERAPEUTICS INC's average Int. Exp. % has been 12.39%.
- The median Int. Exp. % for ZEVRA THERAPEUTICS INC during this period was 6.4%
- ZEVRA THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 40.92%.
- The lowest Int. Exp. % recorded by ZEVRA THERAPEUTICS INC in the same timeframe 0.79%
ZEVRA THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ZEVRA THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 5.03M ] / Revenues [ $ 12.3M ]
(=) Int. Exp. % [ 40.92% ] ZVRA - Interest Expense Margin, Last 5 years
0.79%
Minimum
Dec 31, 2021
40.92%
Maximum
Sep 30, 2020
12.39%
Average
6.4%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |